A recent trial has linked Abbott’s FreeStyle Libre 2 continuous glucose monitor (CGM) to significantly lower blood sugar levels than fingerstick testing. The study, published
All 130,000 Australians with Type 1 diabetes will now get access to subsidised continuous glucose monitoring (CGM) devices under the newly-elected Australian Prime Minister Anthony
The French pharmaceutical giant Sanofi has agreed to pay digital health company Dario Health $30 million to market its diabetes products. In return, Dario Health
A team led by mechanical engineers from the Massachusetts Institute of Technology (MIT) in America has patented two new devices to reduce the rigmarole of
Tandem Diabetes Care has announced that it expects to treble its worldwide customer base to one million people within the next five years, mainly by
Medtronic one of the world’s leading medical device companies, has been hit by a warning letter from the regulatory Food and Drug Administration (FDA) in
Andy Lavender lives near Chester and works at the Cheshire West Integrated Care Partnership. He is a co-ordinator for the Live Well Cheshire West website.
A catch up with Advanced Therapeutics and its range of Dana Diabecare insulin pumps. By Sue Marshall This year the Dana RS insulin pump has
Ultrahuman has raised $17.5m in a Series B financing round for its wearable glucose tracking technology. The India-based company is the developer of Ultrahuman Cyborg –
Following a $50m expansion, Medtronic is to create more than 700 new direct and indirect jobs in the Puerto Rican biosciences sector. Gov. Pedro Pierluisi
